Innate Pharma SA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Marseille
SEC filing record 1 source field available
Fiscal year end
31 December
Innate Pharma SA has filed 337 SEC EDGAR filings since 31 Jan 2014

SEC filing history

Showing 201-225 of 337 matching filings.

Per page
25
Current page
9
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
08 Sep 2022
Reporting date
08 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
06 Sep 2022
Reporting date
05 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
23 Aug 2022
Reporting date
23 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
17 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
01 Aug 2022
Reporting date
01 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
28 Jul 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
21 Jul 2022
Reporting date
21 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
23 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
03 Jun 2022
Reporting date
03 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
20 May 2022
Reporting date
20 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
11 May 2022
Reporting date
11 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
10 May 2022
Reporting date
10 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
10 May 2022
Reporting date
10 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
04 May 2022
Reporting date
03 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
03 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-252074

424B5

Filing date
03 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

6-K

Filing date
03 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
03 May 2022
Reporting date
02 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
29 Apr 2022
Reporting date
29 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
08 Apr 2022
Reporting date
08 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
05 Apr 2022
Reporting date
05 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
24 Mar 2022
Reporting date
24 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
17 Mar 2022
Reporting date
17 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
03 Mar 2022
Reporting date
02 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .